(Q33365707)

26 July 2017

1 reference

title

Current issues in anticoagulation (English)

1 reference

26 July 2017

1 reference

Giancarlo Agnelli

1

1 reference

26 July 2017

publication date

1 January 2005

1 reference

Pathophysiology of Haemostasis and Thrombosis: international journal on haemostasis and thrombosis research

26 July 2017

published in

1 reference

26 July 2017

volume

34 Suppl 1

1 reference

26 July 2017

page(s)

2-9

1 reference

Antithrombotic therapy for venous thromboembolic disease

26 July 2017

cites work

1 reference

Warfarin and other coumarin derivatives: pharmacokinetics, pharmacodynamics, and drug interactions

21 January 2018

1 reference

Atrial fibrillation as an independent risk factor for stroke: the Framingham Study

21 January 2018

1 reference

Cost-effectiveness of anticoagulation in nonrheumatic atrial fibrillation in the primary prevention of ischemic stroke

21 January 2018

1 reference

Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis

21 January 2018

1 reference

Antithrombotic therapy in atrial fibrillation

21 January 2018

1 reference

Atrial fibrillation and antithrombotic treatment in Italian hospitalized patients: a prospective, observational study

21 January 2018

1 reference

Is warfarin underused in the treatment of elderly persons with atrial fibrillation?

21 January 2018

1 reference

Status of antithrombotic therapy for patients with atrial fibrillation in university hospitals

21 January 2018

1 reference

Population based study of use of anticoagulants among patients with atrial fibrillation in the community

21 January 2018

1 reference

Atrial fibrillation: a major contributor to stroke in the elderly. The Framingham Study

21 January 2018

1 reference

Oral anticoagulation in patients with atrial fibrillation: adherence with guidelines in an elderly cohort

21 January 2018

1 reference

Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism

21 January 2018

1 reference

Low-molecular-weight heparin prophylaxis using dalteparin extended out-of-hospital vs in-hospital warfarin/out-of-hospital placebo in hip arthroplasty patients: a double-blind, randomized comparison. North American Fragmin Trial Investigators

21 January 2018

1 reference

Temporal trends in prevention of venous thromboembolism following primary total hip or knee arthroplasty 1996-2001: findings from the Hip and Knee Registry

21 January 2018

1 reference

Short- and long-acting synthetic pentasaccharides

21 January 2018

1 reference

Comparison of ximelagatran with warfarin for the prevention of venous thromboembolism after total knee replacement.

21 January 2018

1 reference

Ximelagatran and melagatran compared with dalteparin for prevention of venous thromboembolism after total hip or knee replacement: the METHRO II randomised trial

21 January 2018

1 reference

The direct thrombin inhibitor melagatran followed by oral ximelagatran compared with enoxaparin for the prevention of venous thromboembolism after total hip or knee replacement: the EXPRESS study

21 January 2018

1 reference

Ximelagatran versus warfarin for stroke prevention in patients with nonvalvular atrial fibrillation. SPORTIF II: a dose-guiding, tolerability, and safety study

21 January 2018

1 reference

Acquired FANCA dysfunction and cytogenetic instability in adult acute myelogenous leukemia.

21 January 2018

1 reference

Secondary Prevention of Venous Thromboembolism with the Oral Direct Thrombin Inhibitor Ximelagatran

21 January 2018

1 reference

Atrial fibrillation and stroke prevention with warfarin in the long-term care setting

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000083078

1 reference

26 July 2017

1 reference